| Product |
CAS |
Molecular formula |
More |
| Tocilizumab |
375823-41-9 |
C23H50ClNO |
More |
| Alemtuzumab |
216503-57-0 |
C38H67NO10 |
More |
| Omalizumab |
242138-07-4 |
C10H15N5O3 |
More |
| Denosumab |
615258-40-7 |
C6404H9908N1724O2004S50 |
More |
| Bevacizumab |
216974-75-3 |
C6638H10160N1720O2108S44 |
More |
| R-tert-butyl 1-(methoxy(methyl)amino)-1-oxopropan-2-ylcarbamate |
87694-49-3 |
C10H20N2O4 |
More |
| 4-Bromo-4’-methylbiphenyl |
844856-52-6 |
C13H11Br |
More |
| (Trans,trans)-4-bromo-4’-ethyl-1,1’-bicyclohexane |
389088-34-0 |
C14H25Br |
More |
| 1-(1-(2-(Trifluoromethyl)phenyl)cyclopropyl)piperazine hydrochloride |
1245643-43-9 |
C14H18ClF3N2 |
More |
| 1-(1-(2-(Trifluoromethyl)phenyl)cyclopropyl)piperazine |
1245646-33-6 |
C14H17F3N2 |
More |
| 1-(1-(4-(Trifluoromethyl)phenyl)cyclopropyl)piperazine |
1245649-95-9 |
C14H17F3N2 |
More |
| 4-Tert-butyl[1,1-biphenyl]-4-amine |
5728-71-2 |
C16H19N |
More |
| Ethyl 2-methyl-3-methylsulfanyl-1h-indole-5-carboxylate |
40015-20-1 |
C13H15NO2S |
More |
| H-d-n-me-leu-obzl·tosoh |
1208162-98-4 |
C21H29NO5S |
More |
| H-ala-ala-ome·hcl |
41036-19-5 |
C7H14N2O3.HCl |
More |
| H-ala-pro-ome·hcl |
71067-42-0 |
C9H17ClN2O3 |
More |
| H-thr(bzl)-obzl·hcl |
67580-86-3 |
C20H23NO7.HCl |
More |
| H-tyr-pna |
52551-07-2 |
C15H15N3O4 |
More |
| H-d-lys(boc)-ome·hcl |
66494-53-9 |
C12H25ClN2O4 |
More |
| H-d-asp(obzl)-obzl·hcl |
174457-99-9 |
|
More |
